Investigation of AstraZeneca’s China president prompts industry calls for more transparency; ‘this is only going to get worse’.
China investigation of drug firm exec deals latest blow to foreign business confidence
RELATED ARTICLES
What Could be the Game-Changing ‘October Surprise’ in the Run-Up to the 2024 Election?
Unable to Wrest Control of Red Sea From Houthis, US and UK Launch Fresh Strikes on Key Yemeni Port
OpenAI Adds Search Engine to ChatGPT
